Head & Neck Clinical Trials
Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.
If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.
Head & Neck
Alliance A091305 - "A Phase 2 Randomized Study Of Efatutazone, An Oral PPAR Agonist, In Combination With Paclitaxel Versus Paclitaxel In Patients With Advanced Anaplastic Thyroid Cancer"
CANCER TYPE: Head & Neck
RESEARCH BASE: Alliance
NCT NUMBER: NCT02152137
Protocol Summary: VIEW SUMMARY
Consent Form: VIEW CONSENT FORM
UPDATED ON 09/19/2018 (19:57:25)
ANAPLASTIC THYROID, metastatic or locally advanced unresectable; Paclitaxel + Efatutazone vs. Paclitaxel alone.